General Information
Version
2.0
Revision date
2018-02-09
Product name
Rebinyn Coagulation Factor (Recombinant), GlycoPEGylated
1.2.1 Relevant identified uses
Closed handling with occasional open handling, e.g. for sampling
1.2.2. Uses advised against
- The full text of any mentioned and identified use categories are given in section 16
Icons in SDS
Company Information
company name
Novo Nordisk A/S
e-mail address of the competent person responsible for the Safety Data Sheet
SDSsupport@novonordisk.com
GHS Information
Signal word
-
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture
Hazard pictograms
-
Signal word
-
Hazard statements
-
Precautionary statements
General -
Prevention
-
Response
-
Storage
-
Disposal
- Identity of the substances primarily responsible for the major health hazards Not applicable
2.3 Other hazards
Consult the package insert Contains a pharmacologically active substance
Additional information
Not applicable Additional warnings Not applicable VOC Not applicable
2.1 Classification of the substance or mixture
Not classified according to Regulation (EC) No. 1272/2008 (CLP)
